Document Detail


Contemporary pharmacological reperfusion in ST elevation myocardial infarction.
MedLine Citation:
PMID:  22596185     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: Fibrinolysis remains a key therapeutic alternative mode of reperfusion in patients with ST segment elevation myocardial infarction (STEMI). Its venerability relates to the wealth of clinical efficacy evidence, ease of administration, and broad applicability to the large number of patients who cannot receive mechanical reperfusion within a reasonable period of time. This review focuses on recent data that will further enhance the clinician's ability to deliver a pharmacological reperfusion strategy to this patient population. RECENT FINDINGS: Combined data from clinical trials as well as registry data support implementation of the guideline endorsed pharmacoinvasive strategy for patients unable to achieve rapid primary percutaneous coronary intervention. The most appropriate mode of reperfusion remains dependent upon the time from symptom onset to presentation as well as perceived delay to initiation of mechanical reperfusion therapy, and one strategy does not fit all patients at all times. Additional information is required in the growing population of elderly patients with STEMI to identify the most appropriate approach to reperfusion in this high-risk population. SUMMARY: Despite extensive investigation concerning the optimal management of STEMI over the last three decades, significant knowledge gaps exist and the efficient application of current evidence to clinical practice remains elusive.
Authors:
Robert C Welsh; Paul W Armstrong
Related Documents :
11166765 - Altered effects of potassium channel modulation in the coronary circulation in experime...
8569215 - Coronary and systemic hemodynamic effects of the putative nitric oxide donor, fk 409, i...
2001035 - Amrinone reverses cardiac depression and augments coronary vasodilation with isoflurane...
9134215 - Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfu...
11779925 - Creatine kinase-mb elevation after stroke is not cardiac in origin: comparison with tro...
11833835 - Bivalirudin: a direct thrombin inhibitor.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-5-16
Journal Detail:
Title:  Current opinion in cardiology     Volume:  -     ISSN:  1531-7080     ISO Abbreviation:  -     Publication Date:  2012 May 
Date Detail:
Created Date:  2012-5-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608087     Medline TA:  Curr Opin Cardiol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Division of Cardiology, Department of Medicine, University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  What is the prevalence of resistant hypertension in the United States?
Next Document:  Nonalcoholic fatty liver disease and vascular risk.